Quinoline

Quinoline

SCHEMBL506172

[S].c1ccc2ncccc2c1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.94
NPC1 O15118 2/20 0.56
POLB P06746 1/20 0.56
RAB9A P51151 1/20 0.56
CYP3A4 P08684 3/20 0.54
MAPT P10636 4/20 0.52
HTT P42858 3/20 0.52
KDM4E B2RXH2 3/20 0.52
CASP1 P29466 2/20 0.52
TP53 P04637 2/20 0.52
HSP90AA1 P07900 2/20 0.52
TSHR P16473 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 1/20 0.52
CASP7 P55210 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
NR4A2 P43354 1/20 0.52
HSP90AB1 P08238 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL1270969 0.97 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL29349552 0.97 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL2774 0.97 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL32661377 0.97 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL29822171 0.97 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL23202414 0.94 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL5714730 0.94 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL2590325 0.94 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL6381814 0.94 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL20969722 0.94 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 511 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174879-A Method for preparing 2-chloronicotinaldehyde 西安凯立新材料股份有限公司 2021-01-05 CN claimed
CN-110054693-A The antibody and application thereof of Quetiapine haptens 詹森药业有限公司 2019-07-26 CN claimed
CN-109803658-A Combined therapy comprising the Imidazopyrazines ketone for treating mental disease and/or cognitive disorder H.隆德贝克有限公司 2019-05-24 CN claimed
CN-104725363-B Substituted diethylenediamine compound and its application method and purposes 广东东阳光药业有限公司 2019-03-01 CN claimed
CN-109142593-A HPLC-DAD method measures Quetiapine drug concentration in human serum 沈阳和合医学检验所有限公司 2019-01-04 CN claimed
CN-106243088-B Substituted diethylenediamine compound and its application method and purposes 广东东阳光药业有限公司 2019-01-04 CN claimed
CN-109069870-A Treatment candidate screening system, model and their application for Huntington's disease based on embryonic cell 洛克菲勒大学 2018-12-21 CN claimed
CN-108165959-A Chemical bronze plating liquid 永星化工(上海)有限公司 2018-06-15 CN claimed
CN-105980858-A Use of sortilin as biomarker for affective/mood disorders H.隆德贝克有限公司 2016-09-28 CN claimed
CN-104193613-B 1,3,5 three (2 carboxy vinyl) benzene and preparation method thereof NANTONG UNIVERSITY (CN) 2016-01-20 CN claimed
CN-120208871-A Quinoline sulfur-containing derivative and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2025-06-27 CN disclosed
CN-111747841-B Preparation method of 4-formylbenzoic acid and obtained 4-formylbenzoic acid 北京博诺安科科技有限公司 2022-09-06 CN disclosed
EP-3329918-B1 C-MET MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2022-05-25 EP disclosed
CN-109438210-B Preparation method of pivalic aldehyde 陕西理工大学 2022-01-07 CN disclosed
CN-109438210-B Preparation method of pivalic aldehyde 陕西理工大学 2022-01-07 CN disclosed
US-4045580-A PHARMACEUTICAL PREPARATION USING 9-(2-HYDROXY-3-AMINO-PROPYL)-9,10-DIHYDRO-9,10-ETHANO-ANTHRACENES AS ANTIDEPRESSANTS CIBA-GEIGY CORPORATION (US) 1977-08-30 US disclosed
US-4017542-A 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and salts thereof CIBA-GEIGY CORPORATION (US) 1977-04-12 US disclosed
US-4011334-A USE OF SUBSTITUTED FURAN AND THIOPHENE CARBOXALDEHYDES AS HYPOLIPIDEMIC AGENTS RICHARDSON-MERRELL INC. (US) 1977-03-08 US disclosed
US-3954862-A RHODIUM CATALYZED HYDROGENATION PFIZER INC. (US) 1976-05-04 US disclosed
US-3931181-A BACTERICIDE HOFFMANN-LA ROCHE INC. (US) 1976-01-06 US disclosed